Federica Sorà

37PUBLICATIONS
102CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCardiology (incl. cardiovascular diseases)Cancer therapy (excl. chemotherapy and radiation therapy)Chemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (37)

|Aug 28, 2026
InflaMix Predicts Severe CRS, ICU Admission, and Progression-Free Survival After CAR-T Therapy in LBCL.

|Jan 11, 2026
Risk factors and reasons for switching from front-line therapy in the Italian chronic myeloid leukaemia network: A cohort study.

Massimo Breccia, Valentina Giai, Tiziana Rosso

|Aug 08, 2025
Routine prophylaxis with levetiracetam offers no benefit in CD19 CAR-T for LBCL: a multicenter propensity-matched study.

Eugenio Galli, Roberta Di Blasi, Alice Di Rocco

|Jun 24, 2025
Frail is not fail: Limited impact of comorbidities on non-relapse mortality and safety in patients with LBCL treated with CAR-T.

Eugenio Galli, Roberta Di Blasi, Ilaria Pansini

|May 09, 2025
Real-World Efficacy Profile of Compassionate Use of Asciminib in an Italian, Multi-Resistant Chronic-Phase Chronic Myeloid Leukemia (CML-CP) Patient Population.

Massimo Breccia, Antonella Russo Rossi, Valentina Giai

|Dec 24, 2024
Baseline Tumor Burden Assessed With AI-Guided PET/CT Total Metabolic Tumor Volume (TMTV) and LDH Levels Predict Efficacy of CAR-T in Aggressive B-Cell Lymphoma.

Eugenio Galli, Andrea Guarneri, Federica Sorà

Pageof 7

Frequent Collaborators

23 joint publications

Patrizia Chiusolo

15 joint publications

Eugenio Galli

13 joint publications

Simona Sica

10 joint publications

Sabrina Giammarco